Michael Lahn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael lahn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Lahn Today - Breaking & Trending Today

iOnctura to present research at leading scientific conferences in June 2023

/PRNewswire/ iOnctura, a clinical-stage biotech developing selective cancer therapies against targets that play critical roles in multiple tumor survival. ....

Noord Holland , Michael Lahn , B Future Health Fund , Uveal Melanoma , Highly Selective Allosteric Modulator , Kinase Delta , Chief Medical Officer , Inkef Capital , Schroders Capital , Future Health ,

iOnctura: Peer-reviewed translational research paves the way for first-in-class autotaxin inhibitor IOA-289 in cancer

AMSTERDAM and GENEVA, May 16, 2023 /PRNewswire/ iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer, today announces the ....

Noord Holland , Michael Lahn , Gewinn Nur , B Future Health Fund , Chief Medical Officer , Inkef Capital , Schroders Capital , Future Health ,

Peer-reviewed translational research paves the way for first-in-class autotaxin inhibitor IOA-289 in cancer

/PRNewswire/ iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer, today announces the. ....

Noord Holland , Michael Lahn , B Future Health Fund , Chief Medical Officer , Inkef Capital , Schroders Capital , Future Health ,

iOnctura reveals new translational cancer research

IOnctura, a clinical stage biotech company developing breakthrough therapies for cancer, has announced the peer-reviewed publication of translational research on the novel autotaxin (ATX) inhibitor IOA-289. ....

Michael Lahn , Bio Developments , Emerging Markets , Research And Development ,